JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC).
Sharma, Maitreyi; Muntean, Alina; le Sourd, Samuel; Vaccaro, Gina M.; Taieb, Julien; Boku, Narikazu; Xiong, Huiling; Conti, Ilaria; Bang, Yung-Jue; Ozguroglu, Mustafa; Moehler, Markus H.; Ryu, Min-Hee; Lee, Keun-Wook; Coskun, Hasan Senol; Wong, Rachel; Chung, Hyun-Choel; Poltoratsky, Artem; Tsuji, Akihito; Yen, Chia-Jui